INVO Fertility Inc
NASDAQ:IVF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
INVO Fertility Inc
NASDAQ:IVF
|
6.8m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
193.9B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.2B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
123.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.2B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.1B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.2B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.5B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.6B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37.8B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
INVO Fertility Inc
Glance View
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for INVO Fertility Inc is 39.2%, which is below its 3-year median of 42.4%.
Over the last 3 years, INVO Fertility Inc’s Gross Margin has decreased from 85.3% to 39.2%. During this period, it reached a low of 36% on Dec 31, 2023 and a high of 85.3% on Sep 30, 2022.
